Literature DB >> 22200956

Effectiveness of synthetic trioxolane OZ78 against Schistosoma japonicum in mice and rabbits.

Shu-Hua Xiao1, Jian Xue, Jing-Yan Mei, Pei-Ying Jiao.   

Abstract

Antischistosomal activities of a synthetic peroxide OZ78 (an ozonide carboxylic acid) against Schistosoma japonicum have been studied in mice and rabbits. Among 132 mice used, 30 of them were infected with 80-100 S. japonicum cercariae for collection of juvenile and adult schistosomes applied in in vitro tests. The remaining 102 mice were infected with 40 schistosome cercariae used for experimental treatment. Other 13 rabbits infected each with 200 schistosome cercariae were treated orally with OZ78 42 days post-infection. Most treated mice and rabbits were sacrificed 4 weeks post-treatment to collect residual schistosomes for evaluation of the drug efficacy. OZ78 and its sodium salt (OZ78-Na salt) 10-60 μg/mL alone exhibited no in vitro effect against day 14, day 21 schistosomula, and day 35 adult schistosomes. But OZ78 and OZ78-Na salt 10 and 20 μg/mL together with hemin 80 μg/mL showed decrease in worm motor activity and severe damage to the worm tegument and intestine, and all worms died within 3 days post-incubation. After infected mice were treated orally with OZ78 at a single dose of 400 mg/kg for 1 day, 34.9% of the worms shifted to the liver. Three and 7 days post-treatment, 100% of the worms were recovered from the liver. Fourteen days post-treatment, 92.3% of the worms still remained in the liver and 7.7% of the worms returned back to the mesenteric veins. Male and female worms shifted to the liver revealed in apparent shrinkage, degeneration of worm body, depigmentation in gut, and disappearance of ova in the uterus of some female worms. Meanwhile, dead worm and dead worm fragments were found in the liver tissues. In mice infected with various stages of schistosomes and treated orally with single OZ78 400 mg/kg, moderate or potential effect of the drug against day 0 (3-h-old worm), day 7, day 14, and day 21 juvenile worms and day 28, day 35 as well as day 42 adult worms were observed, the differences of total or female worm burdens between each treated group and control group were statistically significant (P < 0.01 or P < 0.05). Among the various stages of juveniles, day 7 worms were more susceptible to OZ78 with worm reduction of 83.8%, while the effect of OZ78 against day 28 to day 42 adult worms were similar. Finally, rabbits infected with adult schistosomes and treated with OZ78 at a single dose of 45 mg/kg or a daily dose of 35 mg/kg for three consecutive days resulted in significantly lower total and female worm burdens in comparison with that of control (P < 0.05) with total and female worm reductions of 84.1% and 84.7% as well as 74.3% and 77.4%, respectively. The results demonstrate that OZ78 possesses effect against both juvenile and adult S. japonicum in mouse model, and also shows effect against adult schistosomes in rabbits.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22200956     DOI: 10.1007/s00436-011-2765-x

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  36 in total

Review 1.  Drugs for the control of parasitic diseases: current status and development in schistosomiasis.

Authors:  Alan Fenwick; Lorenzo Savioli; Dirk Engels; N Robert Bergquist; Matthew H Todd
Journal:  Trends Parasitol       Date:  2003-11

Review 2.  [Progress in development of new antischistosomal drugs in recent years].

Authors:  Shu-Hua Xiao
Journal:  Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi       Date:  2010-06-30

3.  Advances in the discovery and development of trematocidal drugs.

Authors:  Jennifer Keiser; Jürg Utzinger
Journal:  Expert Opin Drug Discov       Date:  2007-10       Impact factor: 6.098

4.  Antimalarials. 7. Bis(trifluoromethyl)- -(2-piperidyl)-4-quinolinemethanols.

Authors:  C J Ohnmacht; A R Patel; R E Lutz
Journal:  J Med Chem       Date:  1971-10       Impact factor: 7.446

5.  Susceptibility of Schistosoma japonicum to different developmental stages to praziquantel.

Authors:  S H Xiao; W J Yue; Y Q Yang; J Q You
Journal:  Chin Med J (Engl)       Date:  1987-09       Impact factor: 2.628

Review 6.  Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal.

Authors:  Anthony Danso-Appiah; Sake J De Vlas
Journal:  Trends Parasitol       Date:  2002-03

7.  Artemether administered together with haemin damages schistosomes in vitro.

Authors:  S Xiao; J Chollet; J Utzinger; H Matile; J Mei; M Tanner
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.184

8.  Identification of an antimalarial synthetic trioxolane drug development candidate.

Authors:  Jonathan L Vennerstrom; Sarah Arbe-Barnes; Reto Brun; Susan A Charman; Francis C K Chiu; Jacques Chollet; Yuxiang Dong; Arnulf Dorn; Daniel Hunziker; Hugues Matile; Kylie McIntosh; Maniyan Padmanilayam; Josefina Santo Tomas; Christian Scheurer; Bernard Scorneaux; Yuanqing Tang; Heinrich Urwyler; Sergio Wittlin; William N Charman
Journal:  Nature       Date:  2004-08-19       Impact factor: 49.962

9.  Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire.

Authors:  Giovanna Raso; Eliézer K N'Goran; Abale Toty; Anne Luginbühl; Cynthia A Adjoua; Norbert T Tian-Bi; Isaac I Bogoch; Penelope Vounatsou; Marcel Tanner; Jürg Utzinger
Journal:  Trans R Soc Trop Med Hyg       Date:  2004-01       Impact factor: 2.184

10.  Further study on mefloquine concerning several aspects in experimental treatment of mice and hamsters infected with Schistosoma japonicum.

Authors:  Shu-hua Xiao; Jing-yan Mei; Pei-ying Jiao
Journal:  Parasitol Res       Date:  2009-10-02       Impact factor: 2.289

View more
  9 in total

1.  In vivo schistosomicidal activity of three novels 8-hydroxyquinoline derivatives against adult and immature worms of Schistosoma mansoni.

Authors:  Gamal Allam; Ahmad F Eweas; Abdelaziz S A Abuelsaad
Journal:  Parasitol Res       Date:  2013-06-22       Impact factor: 2.289

2.  In vitro and in vivo activity of 3-alkoxy-1,2-dioxolanes against Schistosoma mansoni.

Authors:  Katrin Ingram; Charles E Schiaffo; Wantanee Sittiwong; Evan Benner; Patrick H Dussault; Jennifer Keiser
Journal:  J Antimicrob Chemother       Date:  2012-05-02       Impact factor: 5.790

3.  Pharmacokinetics of the Antischistosomal Lead Ozonide OZ418 in Uninfected Mice Determined by Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Anna Leonidova; Mireille Vargas; Jörg Huwyler; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

4.  Effect of ozonide OZ418 against Schistosoma japonicum harbored in mice.

Authors:  Jian Xue; Xiaofang Wang; Yuxiang Dong; Jonathan L Vennerstrom; Shu-hua Xiao
Journal:  Parasitol Res       Date:  2014-06-20       Impact factor: 2.289

Review 5.  Repurposing drugs for the treatment and control of helminth infections.

Authors:  Gordana Panic; Urs Duthaler; Benjamin Speich; Jennifer Keiser
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-07-30       Impact factor: 4.077

Review 6.  Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies.

Authors:  Shu-Hua Xiao; Jun Sun; Ming-Gang Chen
Journal:  Infect Dis Poverty       Date:  2018-02-07       Impact factor: 4.520

Review 7.  Peroxides with Anthelmintic, Antiprotozoal, Fungicidal and Antiviral Bioactivity: Properties, Synthesis and Reactions.

Authors:  Vera A Vil'; Ivan A Yaremenko; Alexey I Ilovaisky; Alexander O Terent'ev
Journal:  Molecules       Date:  2017-11-02       Impact factor: 4.411

8.  Modulation of mice immune responses against Schistosoma mansoni infection with anti-schistosomiasis drugs: Role of interleukin-4 and interferon-gamma.

Authors:  Osama F Sharaf; Ahmed A Ahmed; Asmaa F Ibrahim; Ali Shariq; Abdullah S Alkhamiss; Ruqaih Alghsham; Sami A Althwab; Sultan A Alghaniam; Fahad A Alhumaydhi; Rana Alghamdi; Ahmad Alshomar; Tasleem Alabdullatif; Abdulrahman Alkhulayfi; Abdulrhman A Alghunaim; Waleed Al Abdulmonem
Journal:  Int J Health Sci (Qassim)       Date:  2022 Mar-Apr

9.  Elimination of Schistosoma mansoni in infected mice by slow release of artemisone.

Authors:  Daniel Gold; Mohammed Alian; Avraham Domb; Yara Karawani; Maysa Jbarien; Jacques Chollet; Richard K Haynes; Ho Ning Wong; Viola Buchholz; Andreas Greiner; Jacob Golenser
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-05-04       Impact factor: 4.077

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.